Edition:
United States

EnteroMedics Inc (ETRM.OQ)

ETRM.OQ on NASDAQ Stock Exchange Capital Market

4.98USD
23 Jun 2017
Change (% chg)

-- (--)
Prev Close
$4.98
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
121,377
52-wk High
$31.49
52-wk Low
$1.76

ETRM.OQ

Chart for ETRM.OQ

About

EnteroMedics Inc. (EnteroMedics) is a medical device company. The Company is focused on the design and development of devices that use neuroblocking technology to treat obesity, metabolic diseases and other gastrointestinal disorders. The Company's neuroblocking technology, which is referred to as VBLOC therapy, is designed to... (more)

Overall

Beta: 3.06
Market Cap(Mil.): $34.40
Shares Outstanding(Mil.): 6.91
Dividend: --
Yield (%): --

Financials

  ETRM.OQ Industry Sector
P/E (TTM): -- 38.61 19.01
EPS (TTM): -49.65 -- --
ROI: -198.77 8.77 -5.03
ROE: -279.50 13.56 -4.28

BRIEF-EnteroMedics announces first vBloc neurometabolic therapy

* EnteroMedics announces first vBloc® neurometabolic therapy implant at AMITA health adventist medical center Bolingbrook Source text for Eikon: Further company coverage:

May 31 2017

BRIEF-Enteromedics announces the acquisition of the Gastric Vest System

* Enteromedics announces the acquisition of the Gastric Vest System

May 23 2017

BRIEF-EnteroMedics Q1 loss per share $1.27

* Enteromedics inc - for three months ended march 31, 2017, company reported sales of $40,000 with gross profits totaling $11,000

May 16 2017

BRIEF-Enteromedics Inc files for a mixed shelf of upto $75 mln - SEC filing

* Files for a mixed shelf of upto $75 million - SEC filing Source text - http://bit.ly/2muv39M Further company coverage:

Mar 10 2017

BRIEF-CVI INVESTMENTS REPORTS 9.9 PERCENT PASSIVE STAKE IN ENTEROMEDICS

* REPORTS 9.9 PERCENT PASSIVE STAKE IN ENTEROMEDICS INC AS OF JAN. 18 - SEC FILING Source text (http://bit.ly/2kpqkSH) Further company coverage:

Jan 24 2017

More From Around the Web

Earnings vs. Estimates